Here, we present a case of ATLL in a male patient that experienced a significant and durable response to 9-ING-41 monotherapy, a potent small molecule inhibitor of glycogen synthase kinase-3 beta (GSK-3β), following three lines of prior treatments. Here, GSK3B is linked to adult T-cell leukemia/lymphoma.